| Placebo (n = 16) | ET (n = 18) | EPT (n = 17) | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | 12 weeks | Change from baseline | Baseline | 12 weeks | Change from baseline | Baseline | 12 weeks | Change from baseline | |
PWV | 15.8 ± 2.2 | 16.3 ± 2.9 | 0.3 ± 1.5 | 15.2 ± 1.6 | 14.6 ± 1.7 | -0.6 ± 1.6 | 15.4 ± 1.7 | 14.9 ± 1.3 | -0.6 ± 1.4a |
Ao SBP | 137.3 ± 14.2 | 134.6 ± 13.7 | -3.3 ± 13.8 | 135.9 ± 10.6 | 128.1 ± 18.3 | -7.9 ± 15.3 | 140.9 ± 14.6 | 136.7 ± 16.2 | -6.6 ± 17.0 |
Ao DBP | 85.2 ± 10.5 | 86.3 ± 9.9 | 0.4 ± 7.5 | 87.7 ± 6.0 | 82.1 ± 10.3 | -5.6 ± 9.1a | 90.1 ± 9.0 | 87.9 ± 10.0 | -3.6 ± 8.2 |
Ao PP | 52.1 ± 7.7 | 48.3 ± 7.4 | -3.7 ± 8.6 | 48.3 ± 9.7 | 46.0 ± 13.4 | -2.3 ± 10.1 | 50.8 ± 11.3 | 48.8 ± 12.0 | -2.9 ± 11.6 |
AIx | 0.40 ± 0.09 | 0.39 ± 0.09 | 0.0 ± 0.1 | 0.39 ± 0.05 | 0.35 ± 0.07 | 0.0 ± 0.1a | 0.40 ± 0.09 | 0.39 ± 0.09 | 0.0 ± 0.1 |
cAIx | 0.35 ± 0.07 | 0.34 ± 0.06 | 0.0 ± 0.1 | 0.33 ± 0.05 | 0.34 ± 0.06 | 0.0 ± 0.1 | 0.35 ± 0.08 | 0.33 ± 0.07 | 0.0 ± 0.1 |